{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:27:08Z","timestamp":1770823628429,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1007\/s11864-001-0022-8","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T20:32:53Z","timestamp":1183581173000},"page":"291-300","source":"Crossref","is-referenced-by-count":24,"title":["Human T-cell lymphotropic-I-associated leukemia\/lymphoma"],"prefix":"10.1007","volume":"2","author":[{"given":"Richard S.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald B.","family":"Gartenhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Kuzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-4362.1990.tb03791.x","volume":"29","author":"DJ Gross","year":"1990","unstructured":"Gross DJ, Kavanaugh A:HTLV-I. Int J Dermatol 1990, 29:161\u2013165.","journal-title":"Int J Dermatol"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","volume":"353","author":"A Manns","year":"1999","unstructured":"Manns A, Hisada M, La Grenade L:Human T-lymphotropic virus type I infection. Lancet 1999, 353:1951\u20131958.","journal-title":"Lancet"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2141.1998.00582.x","volume":"100","author":"R Pawson","year":"1998","unstructured":"Pawson R, Mufti GJ, Pagliuca A:Management of adult T-cell leukemia\/lymphoma. Br J Haematol 1998, 100:453\u2013458.","journal-title":"Br J Haematol"},{"key":"22_CR4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, et al.:Adult T-cell leukemia:clinical and hematologic features of 16 cases. Blood 1977, 50:481\u2013492.","journal-title":"Blood"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, et al.:Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980, 77:7415\u20137419.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(94)90994-6","volume":"343","author":"K Yamaguchi","year":"1994","unstructured":"Yamaguchi K:Human T-lymphotropic virus type I in Japan. Lancet 1994, 343:213\u2013216.","journal-title":"Lancet"},{"issue":"suppl","key":"22_CR7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/00042560-199600001-00004","volume":"13","author":"K Takatsuki","year":"1996","unstructured":"Takatsuki K, Matsuoka M, Yamaguchi K: Adult T-cell leukemia in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl):S15-S19.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"suppl","key":"22_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00042560-199600001-00002","volume":"13","author":"N Mueller","year":"1996","unstructured":"Mueller N, Okayama A, Stuver S, et al.:Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl):S2-S7.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/00042560-199600001-00003","volume":"13","author":"GP Taylor","year":"1996","unstructured":"Taylor GP:The epidemiology of HTLV-I in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:S8-S14.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"suppl","key":"22_CR10","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","volume":"13","author":"B Hanchard","year":"1996","unstructured":"Hanchard B:Adult T-cell leukemia\/lymphoma in Jamaica:1986-1995. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl):S20-S25.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0140-6736(85)90391-5","volume":"2","author":"N Tubiana","year":"1985","unstructured":"Tubiana N, Lejeune C, Lecaer F, et al.:T-Lymphoma associated with HTLV-I outside the Caribbean and Japan. Lancet 1985, 2:337\u2013338.","journal-title":"Lancet"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-106-3-361","volume":"106","author":"WN Gibbs","year":"1987","unstructured":"Gibbs WN, Lofters WS, Campbell M, et al.:Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia\/lymphoma. Ann Intern Med 1987, 106:361\u2013368.","journal-title":"Ann Intern Med"},{"key":"22_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00042560-199606010-00014","volume":"12","author":"JE Kaplan","year":"1996","unstructured":"Kaplan JE, Khabbaz RF, Murphy EL, et al.:Male-tofemale transmission of human T-cell lymphotropic virus types I and II:association with viral load. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:193\u2013201.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00042560-199606010-00013","volume":"12","author":"PN Nyambi","year":"1996","unstructured":"Nyambi PN, Ville Y, Louwagie J, et al.:Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I\/II) in Gabon:a prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:187\u2013192.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(83)92613-2","volume":"2","author":"A Komuro","year":"1983","unstructured":"Komuro A, Hayami M, Fujii H, et al.:Vertical transmission of adult T-cell leukaemia virus. Lancet 1983, 2:240.","journal-title":"Lancet"},{"key":"22_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V74.1.388.388","volume":"74","author":"YC Chen","year":"1989","unstructured":"Chen YC, Wang CH, Su IJ, et al.:Infection of human T-cell leukemia virus type I and development of human T-cell leukemia\/lymphoma in patients with hematologic neoplasms:a possible linkage to blood transfusion. Blood 1989, 74:388\u2013394.","journal-title":"Blood"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(95)90721-1","volume":"345","author":"J Giesecke","year":"1995","unstructured":"Giesecke J:HTLV screening of Swedish blood donors. Lancet 1995, 345:978.","journal-title":"Lancet"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(86)91636-3","volume":"2","author":"M Osame","year":"1986","unstructured":"Osame M, Izumo S, Igata A, et al.:Blood transfusion and HTLV-I associated myelopathy. Lancet 1986, 2:104\u2013105.","journal-title":"Lancet"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.307.6914.1235","volume":"307","author":"M Brennan","year":"1993","unstructured":"Brennan M, Runganga J, Barbara JA, et al.:Prevalence of antibodies to human T cell leukaemia\/lymphoma virus in blood donors in north London. Br Med J 1993, 307:1235\u20131239.","journal-title":"Br Med J"},{"key":"22_CR20","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/bmj.307.6914.1224","volume":"307","author":"AG Dalgleish","year":"1993","unstructured":"Dalgleish AG:Human T-cell leukaemia\/lymphoma virus and blood donation. Br Med J 1993, 307:1224\u20131225.","journal-title":"Br Med J"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0140-6736(90)91177-C","volume":"335","author":"J Coste","year":"1990","unstructured":"Coste J, Lemaire JM, Barin F, et al.:HTLV-I\/II antibodies in French blood donors. Lancet 1990, 335:1167\u20131168.","journal-title":"Lancet"},{"issue":"suppl","key":"22_CR22","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1097\/00042560-199600001-00012","volume":"13","author":"M Yoshida","year":"1996","unstructured":"Yoshida M:Molecular biology of HTLV-I:recent progress. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl):S63-S68.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","volume":"86","author":"G Franchini","year":"1995","unstructured":"Franchini G:Molecular mechanisms of human T-cell leukemia\/lymphotropic virus type I infection. Blood 1995, 86:3619\u20133639.","journal-title":"Blood"},{"key":"22_CR24","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood.V82.9.2823.2823","volume":"82","author":"K Nagafuji","year":"1993","unstructured":"Nagafuji K, Harada M, Teshima T, et al.:Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1. Blood 1993, 82:2823\u20132828.","journal-title":"Blood"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1073\/pnas.86.9.3351","volume":"86","author":"R Grassman","year":"1989","unstructured":"Grassman R, Dengler C, Muller-Fleckenstein I, et al.:Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci U S A 1989, 86:3351\u20133355.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/viro.2000.0445","volume":"274","author":"M Makino","year":"2000","unstructured":"Makino M, Wakamatsu S, Shimokubo S, et al.:Production of functionally deficient dendritic cells from HTLV-I infected monocytes:implications for the dendritic cell defect in adult T-cell leukemia. Virology 2000, 274:140\u2013148. This is a speculative experimental work suggesting further approaches to biologic therapies for this disease.","journal-title":"Virology"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","volume":"96","author":"C Nicot","year":"2000","unstructured":"Nicot C, Mahieux R, Takemoto S, Franchini G:Bcl-XL is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. Blood 2000, 96:275\u2013281. Novel targets for therapy are identified.","journal-title":"Blood"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/j.1460-2075.1996.tb00505.x","volume":"15","author":"T Suzuki","year":"1996","unstructured":"Suzuki T, Kitao S, Matsushime H, et al.:HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J 1996, 15:1607\u20131614.","journal-title":"EMBO J"},{"issue":"suppl","key":"22_CR29","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/00042560-199600001-00013","volume":"13","author":"A Cereseto","year":"1996","unstructured":"Cereseto A, Mulloy JC, Franchini G:Insights on the pathogenicity of human T-lymphotropic\/leukemia virus types I and II. J Acquir Immune Defic Syndr 1996, 13(suppl):S69-S75.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"22_CR30","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V92.10.3557.422k09_3557_3561","volume":"92","author":"M Hisada","year":"1998","unstructured":"Hisada M, Okayama A, Shiori S, et al.:Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 1998, 92:3557\u20133561.","journal-title":"Blood"},{"key":"22_CR31","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood.V85.7.1865.bloodjournal8571865","volume":"85","author":"Y Furukawa","year":"1995","unstructured":"Furukawa Y, Osame M, Kubota R, et al.:Human T-cell leukemia virus type-1 (HTLV-1) tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995, 85:1865\u20131870.","journal-title":"Blood"},{"key":"22_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood.V66.1.120.120","volume":"66","author":"K Kinoshita","year":"1985","unstructured":"Kinoshita K, Amagaski T, Ikeda S, et al.:Preleukemic state of adult T-cell leukemia:abnormal T lymphocytosis induced by human adult T-cell leukemialymphoma virus. Blood 1985, 66:120\u2013127.","journal-title":"Blood"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/0140-6736(91)92413-V","volume":"338","author":"B Hanchard","year":"1991","unstructured":"Hanchard B, LaGrenade L, Carberry C, et al.:Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet 1991, 338:1593\u20131594.","journal-title":"Lancet"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jnci\/90.8.617","volume":"90","author":"A Manns","year":"1998","unstructured":"Manns A, Hanchard B, Morgan OS, et al.:Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia\/lymphoma in a black population. J Natl Cancer Inst 1998, 90:617\u2013622.","journal-title":"J Natl Cancer Inst"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S0301-472X(99)00053-3","volume":"27","author":"N Arima","year":"1999","unstructured":"Arima N, Matsushita K, Obata H, et al.:NF-KB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hematol 1999, 27:1168\u20131175. Interesting article about a possible mechanism of activation that may provide novel molecular targets for therapy.","journal-title":"Exp Hematol"},{"key":"22_CR36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M, and Members of the Lymphoma Study Group:Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Haematol 1991, 79:428\u2013437.","journal-title":"Br J Haematol"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood.V84.9.3080.3080","volume":"84","author":"S Takemoto","year":"1994","unstructured":"Takemoto S, Matsuoka M, Yamaguchi K, et al.:A novel diagnostic method of adult T-cell leukemia:monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 1994, 84:3080\u20133085.","journal-title":"Blood"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM198308043090501","volume":"309","author":"PA Bunn","year":"1983","unstructured":"Bunn PA, Schecter GP, Jaffe E, et al.:Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med 1983, 309:257\u2013264.","journal-title":"N Engl J Med"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/1097-0142(19850215)55:4<851::AID-CNCR2820550424>3.0.CO;2-J","volume":"55","author":"F Kawano","year":"1985","unstructured":"Kawano F, Yamaguchi K, Nishimura H, et al.:Variation in the clinical courses of adult T-cell leukemia. Cancer 1985, 55:851\u2013856.","journal-title":"Cancer"},{"key":"22_CR40","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/bmj.297.6661.1456","volume":"297","author":"A Pagliuca","year":"1988","unstructured":"Pagliuca A, Layton DM, Allen S, et al.:Hyperinfection with strongyloides after treatment for adult T-cell leukaemia-lymphoma in an African immigrant. Br Med J 1988, 297:1456\u20131457.","journal-title":"Br Med J"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0140-6736(91)90929-J","volume":"337","author":"H Taguchi","year":"1991","unstructured":"Taguchi H, Kobayashi M, Miyoshi I:Immunosuppression by HTLV-I infection. Lancet 1991, 337:308.","journal-title":"Lancet"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0145-2126(91)90087-A","volume":"15","author":"Lymphoma Study Group","year":"1991","unstructured":"Lymphoma Study Group:Major prognostic factors of patients with adult T-cell leukemia-lymphoma:a cooperative study. Leuk Res 1991, 15:81\u201390.","journal-title":"Leuk Res"},{"key":"22_CR43","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.1988.6.7.1088","volume":"6","author":"M Shimoyama","year":"1988","unstructured":"Shimoyama M, Ota K, Kikuchi M, et al.:Major prognostic factors of adult patients with advanced T-cell lymphoma\/leukemia. J Clin Oncol 1988, 6:1088\u20131097.","journal-title":"J Clin Oncol"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/1097-0142(19910515)67:10<2605::AID-CNCR2820671034>3.0.CO;2-L","volume":"67","author":"Y Yamada","year":"1991","unstructured":"Yamada Y, Murata K, Kamihira S, et al.:Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia. Cancer 1991, 67:2605\u20132609.","journal-title":"Cancer"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0145-2126(92)90168-7","volume":"16","author":"S Kamihira","year":"1992","unstructured":"Kamihira S, Sohda H, Atogami S, et al.:Phenotypic diversity and prognosis of adult T-cell leukemia. Leuk Res 1992, 16:435\u2013441.","journal-title":"Leuk Res"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0145-2126(91)90089-C","volume":"15","author":"N Sadamori","year":"1991","unstructured":"Sadamori N, Ikeda S, Yamaguchi K, et al.:Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders. Leuk Res 1991, 15:99\u2013103.","journal-title":"Leuk Res"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","volume":"73","author":"S Kamihira","year":"1994","unstructured":"Kamihira S, Atogami S, Sohda H, et al.:Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 1994, 73:2753\u20132758.","journal-title":"Cancer"},{"key":"22_CR48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","volume":"89","author":"K Tsukasaki","year":"1997","unstructured":"Tsukasaki K, Tsushima H, Yamamura M, et al.:Integration patterns of HTLV-I provirus in relation to the clinical course of ATL:frequent clonal change at crisis from indolent disease. Blood 1997, 89:948\u2013956.","journal-title":"Blood"},{"key":"22_CR49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/10428199909167395","volume":"32","author":"Y","year":"1999","unstructured":"Hayami|Y, Komatsu H, Iida S, et al.:Microsattelite instability as a potential marker for poor prognosis in adult T-cell leukemia\/lymphoma. Leuk Lymph 1999, 32:345\u2013349. Experimental findings that may provide a molecular marker for patients with poor prognosis who could be studied earlier with novel interventions.","journal-title":"Leuk Lymph"},{"issue":"suppl","key":"22_CR50","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1097\/00042560-199600001-00023","volume":"13","author":"B Renjifo","year":"1996","unstructured":"Renjifo B, Chou K, Ramirez LS, et al.:Human T-cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl):S146-S153.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR51","first-page":"746","volume":"87","author":"SA Peter","year":"1995","unstructured":"Peter SA, Cervantes JF:Hypercalcemia associated with adult T-cell leukemia\/lymphoma (ATL). J Natl Med Assoc 1995, 87:746\u2013748.","journal-title":"J Natl Med Assoc"},{"key":"22_CR52","first-page":"166","volume":"21","author":"K Ikeda","year":"1995","unstructured":"Ikeda K, Inoue D, Okazaki R, et al.:Parathyroid hormone-related peptide in hypercalcemia associated with adult T cell leukemia\/lymphoma:molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-I-infected T cells. Miner Electrolyte Metab 1995, 21:166\u2013170.","journal-title":"Miner Electrolyte Metab"},{"key":"22_CR53","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1001\/archinte.146.10.1971","volume":"146","author":"RC Dodd","year":"1986","unstructured":"Dodd RC, Winkler CF, Williams ME, et al.:Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med 1986, 146:1971\u20131972.","journal-title":"Arch Intern Med"},{"key":"22_CR54","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archinte.148.4.921","volume":"148","author":"S Fukumoto","year":"1988","unstructured":"Fukumoto S, Matsumoto T, Ikeda K, et al.:Clinical evidence of calcium metabolism in adult T-cell leukemia\/ lymphoma. Arch Intern Med 1988, 148:921\u2013925.","journal-title":"Arch Intern Med"},{"key":"22_CR55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-111-6-484","volume":"111","author":"T Motokura","year":"1989","unstructured":"Motokura T, Fukumoto S, Matsumoto T, et al.:Parathyroid hormone-related protein in adult T-cell leukemia\/lymphoma. Ann Intern Med 1989, 111:484\u2013488.","journal-title":"Ann Intern Med"},{"key":"22_CR56","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1210\/jc.79.5.1322","volume":"79","author":"K Ikeda","year":"1994","unstructured":"Ikeda K, Ohno H, Hane M, Yokoi H, et al.:Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide:evidence for elevated levels in plasma from patients with adult T-cell leukemia\/lymphoma and B-cell lymphoma. J Clin Endocrinol Metab 1994, 79:1322\u20131327.","journal-title":"J Clin Endocrinol Metab"},{"key":"22_CR57","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0021-9258(18)54056-4","volume":"268","author":"K Ikeda","year":"1993","unstructured":"Ikeda K, Okazaki R, Inoue D, et al.:Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells. J Biol Chem 1993, 268:1174\u20131179.","journal-title":"J Biol Chem"},{"key":"22_CR58","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1210\/en.132.6.2551","volume":"132","author":"K Ikeda","year":"1993","unstructured":"Ikeda K, Okazaki R, Inoue D, et al.:Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells:possible role in hypercalcemia associated with adult T-cell leukemia. Endocrinology 1993, 132:2551\u20132556.","journal-title":"Endocrinology"},{"key":"22_CR59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood.V81.4.1017.1017","volume":"81","author":"E Ejima","year":"1993","unstructured":"Ejima E, Rosenblatt J, Massari M, et al.:Cell-typespecific transactivation of the parathyroid hormonerelated protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. Blood 1993, 81:1017\u20131024.","journal-title":"Blood"},{"key":"22_CR60","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1084\/jem.172.3.759","volume":"172","author":"T Watanabe","year":"1990","unstructured":"Watanabe T, Yamaguchi K, Takatsuki K, et al.:Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type I (HTLV-I) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-I tax gene. J Exp Med 1990, 172:759\u2013765.","journal-title":"J Exp Med"},{"key":"22_CR61","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1128\/jvi.67.10.6087-6095.1993","volume":"67","author":"J Dittmer","year":"1993","unstructured":"Dittmer J, Gitlin S, Reid R, et al.:Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I tax1:evidence for the involvement of transcription factor Ets1. J Virol 1993, 67:6087\u20136095.","journal-title":"J Virol"},{"key":"22_CR62","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","volume":"12","author":"H Taguchi","year":"1996","unstructured":"Taguchi H, Kinoshita KI, Takatsuki K, et al.:An intensive chemotherapy of adult T-cell leukemia\/lymphoma:CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 12:182\u2013186.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR63","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood.V81.10.2810.2810","volume":"81","author":"JA Sparano","year":"1993","unstructured":"Sparano JA, Wiernik PH, Strack M, et al.:Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus-, and human T-cell leukemia virus type I-related non-Hodgkin\u2019s lymphoma:a highly active regimen. Blood 1993, 81:2810\u20132815.","journal-title":"Blood"},{"key":"22_CR64","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/bjc.1994.394","volume":"70","author":"H Tsuda","year":"1994","unstructured":"Tsuda H, Takatsuki K, Ohno R, et al.:Treatment of adult T-cell leukemia-lymphoma with irinotecan hydrochloride (CPT-11). Br J Cancer 1994, 70:771\u2013774.","journal-title":"Br J Cancer"},{"key":"22_CR65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0140-6736(92)91052-A","volume":"339","author":"F Brito-Babapulle","year":"1992","unstructured":"Brito-Babapulle F, Arya R, Griffiths T, et al.:BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma. Lancet 1992, 339:133\u2013134.","journal-title":"Lancet"},{"key":"22_CR66","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/1097-0142(19871201)60:11<2605::AID-CNCR2820601104>3.0.CO;2-T","volume":"60","author":"W Lofters","year":"1987","unstructured":"Lofters W, Campbell M, Gibbs N, et al.:2\u2019-Deoxycoformycin therapy in adult T-cell leukemia\/lymphoma. Cancer 1987, 60:2605\u20132608.","journal-title":"Cancer"},{"key":"22_CR67","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0145-2126(86)90251-1","volume":"10","author":"K Yamaguchi","year":"1996","unstructured":"Yamaguchi K, Yul LS, Oda T, et al.:Clinical consequences of 2\u2019-deoxycoformycin treatment in patients with refractory adult T-cell leukemia. Leuk Res 1996, 10:989\u2013993.","journal-title":"Leuk Res"},{"key":"22_CR68","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/1097-0142(19930401)71:7<2217::AID-CNCR2820710709>3.0.CO;2-8","volume":"71","author":"R Ohno","year":"1993","unstructured":"Ohno R, Masaoka T, Shirakawa S, et al.:Treatment of adult T-cell leukemia\/lymphoma with MST-16, a new oral antitumor drug and a derivative of Bis (2,6-dioxopiperazine). Cancer 1993, 71:2217\u20132221.","journal-title":"Cancer"},{"key":"22_CR69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","volume":"17","author":"K Tsukasaki","year":"1993","unstructured":"Tsukasaki K, Ikeda S, Murata K, et al.:Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia\/ lymphoma. Leuk Res 1993, 17:157\u2013166.","journal-title":"Leuk Res"},{"key":"22_CR70","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2141.1996.02338.x","volume":"94","author":"A Borg","year":"1996","unstructured":"Borg A, Yin JA, Johnson PR, et al.:Successful treatment of HTLV-I-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol 1996, 94:713\u2013715.","journal-title":"Br J Haematol"},{"key":"22_CR71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1994.tb05040.x","volume":"88","author":"P Ljungman","year":"1994","unstructured":"Ljungman P, Lawler M, Asjo B, et al.:Infection of donor lymphocytes with human T lymphotropic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol 1994, 88:403\u2013405.","journal-title":"Br J Haematol"},{"key":"22_CR72","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2141.1995.tb08399.x","volume":"89","author":"I Miyoshi","year":"1995","unstructured":"Miyoshi I, Murata N, Machida H, et al.:Transmission of human T-lymphotropic virus type 1 by bone marrow transplantation. Br J Haematol 1995, 89:690\u2013691.","journal-title":"Br J Haematol"},{"key":"22_CR73","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V76.10.2065.2065","volume":"76","author":"Y Kuwazuru","year":"1990","unstructured":"Kuwazuru Y, Hanada S, Furukawa T, et al.:Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990, 76:2065\u20132071.","journal-title":"Blood"},{"key":"22_CR74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275.013k43_275_281","volume":"96","author":"C Nicot","year":"2000","unstructured":"Nicot C, Mahieux R, Takemoto S, Franchini G:Bel-XL is up-regulated by HTLV-1 and HTLV-II in vitro and in ex vivo ATLL samples. Blood 2000, 96:275\u2013281.","journal-title":"Blood"},{"key":"22_CR75","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W, Kaplan MH, et al.:Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995, 332:1744\u20131748.","journal-title":"N Engl J Med"},{"issue":"suppl","key":"22_CR76","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","volume":"13","author":"A Bazarbachi","year":"1996","unstructured":"Bazarbachi A, Hermine O:Treatment with a combination of zidovudine and \u03b1-interferon in na\u00efve and pretreated adult T-cell leukemia\/lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(suppl):S186-S190.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"22_CR77","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A, et al.:Brief report:treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995, 332:1749\u20131751.","journal-title":"N Engl J Med"},{"key":"22_CR78","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0190-9622(99)70543-8","volume":"40","author":"EF Chan","year":"1999","unstructured":"Chan EF, Dowdy YG, Lee B, et al.:A novel chemotherapeutic (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction. J Am Acad Dermatol 1999, 40:116\u2013121.","journal-title":"J Am Acad Dermatol"},{"key":"22_CR79","first-page":"2540","volume":"5","author":"J Dierov","year":"1999","unstructured":"Dierov J, Sawaya B, Prosniak M, et al.:Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells. Clin Cancer Res 1999, 5:2540\u20132547.","journal-title":"Clin Cancer Res"},{"key":"22_CR80","doi-asserted-by":"publisher","first-page":"31723","DOI":"10.1074\/jbc.271.49.31723","volume":"271","author":"M Liu","year":"1996","unstructured":"Liu M, Iavarone A, Freedman L:Transcriptional activation of the human p21WAF\/CIP1 gene by retinoic acid receptor. J Biol Chem 1996, 271:31723\u201331728.","journal-title":"J Biol Chem"},{"key":"22_CR81","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/1097-0142(19870315)59:6<1059::AID-CNCR2820590602>3.0.CO;2-M","volume":"59","author":"K Tamura","year":"1987","unstructured":"Tamura K, Makino S, Araki Y, et al.:Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer 1987, 59:1059\u20131062.","journal-title":"Cancer"},{"key":"22_CR82","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/1097-0142(19910815)68:4<695::AID-CNCR2820680405>3.0.CO;2-K","volume":"68","author":"K Ezaki","year":"1991","unstructured":"Ezaki K, Hirano M, Ohno R, et al.:A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia\/lymphoma. Cancer 1991, 68:695\u2013698.","journal-title":"Cancer"},{"key":"22_CR83","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","volume":"82","author":"TA Waldmann","year":"1993","unstructured":"Waldmann TA, White JD, Goldman CK, et al.:The interleukin-2 receptor:a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 1993, 82:1701\u20131712.","journal-title":"Blood"},{"key":"22_CR84","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","volume":"86","author":"TA Waldmann","year":"1995","unstructured":"Waldmann TA, White JD, Carrasquillo JA, et al.:Radioimmunotherapy of interleukin-2R\u03b1-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood 1995, 86:4063\u20134075.","journal-title":"Blood"},{"key":"22_CR85","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1365-2141.1998.01068.x","volume":"103","author":"K Ishitsuka","year":"1998","unstructured":"Ishitsuka K, Hanada S, Suzuki S, et al.:Arsenic trioxide inhibits growth of human T-cell leukemia virus type I infected T-cell lines more effectively than retinoic acids. Br J Haematol 1998, 103:721\u2013728.","journal-title":"Br J Haematol"},{"issue":"suppl","key":"22_CR86","first-page":"S191","volume":"13","author":"GD The","year":"1996","unstructured":"The GD, Kazanji M:An HTLV-I\/II vaccine:From animal models to clinical trials? J Acquir Immune Defic Syndr Hum Retrivirol 1996, 13(suppl):S191-S198.","journal-title":"J Acquir Immune Defic Syndr Hum Retrivirol"},{"key":"22_CR87","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/aid.1993.9.381","volume":"9","author":"GD The","year":"1993","unstructured":"The GD, Bomford R:An HTLV-I vaccine:why, how, for whom? AIDS Res Hum Retroviruses 1993, 9:381\u2013386.","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-001-0022-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0022-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-001-0022-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T14:23:16Z","timestamp":1652624596000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-001-0022-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11864-001-0022-8","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}